Wanda D Ryan, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2000 Oxford Dr, Bethel Park, PA 15102 Phone: 412-854-3491 |
Jann M. Johnston, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2000 Oxford Dr, Suite 200, Bethel Park, PA 15102 Phone: 412-942-2140 Fax: 412-942-6027 |
Douha Safar, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2000 Oxford Dr, Suite 200, Bethel Park, PA 15102 Phone: 412-942-2140 Fax: 412-942-6027 |
Bridget Beier, DO Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2000 Oxford Dr, Suite 200, Bethel Park, PA 15102 Phone: 412-942-2140 Fax: 412-942-6027 |
Camille M Buonocore, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2000 Oxford Dr, Suite 200, Bethel Park, PA 15102 Phone: 412-942-2140 Fax: 412-942-6027 |
News Archive
This Justice Department step is being viewed as a signal that the Obama administration wants the high court to decide the question of the health law's constitutionality before the 2012 presidential election.
Our understanding of the importance of microRNAs in regulating gene expression is expanding, and with it our requirement for robust methods to measure their expression levels. Now a new method published in BioMed Central's open access journal Genome Biology helps researchers to better understand the delicate interplay between differences in microRNA expression levels and their target genes.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the third quarter ended September 30, 2011.
Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics, announced today the acquisition of the world's largest cryo-preserved human cancer tissue bankāmore than 144,000 specimens procured over 20 years. The company acquired the tumor bank, along with properly de-identified clinical information and validated test procedures, as part of a major acquisition of key assets formerly owned by Oncotech.
› Verified 4 days ago